St. Jude Medical gets approval, prepares market launch for cardiac-care device

By Elaine Rigoli

Tampa, Fla., April 17 - St. Jude Medical, Inc. has received Food and Drug Administration approval and is preparing the market launch of its Merlin Patient Care System, a universal programmer for implantable cardioverter defibrillators (ICDs) and pacemakers.

The system is designed to help physicians more efficiently conduct tests, analyze therapeutic and diagnostic data and program implanted devices, according to a news release.

Patients with pacemakers or ICDs require regular follow-up exams to make sure devices are delivering appropriate therapy and to review changes in patient health. If a patient's condition has changed, clinicians can program new instructions into the device to help protect the patient from abnormal heart rhythms.

The system, which supports current and previous generation devices, is one of more than 20 new cardiac rhythm management products expected to be introduced this year, the release said.

St. Jude Medical will launch the new system over the coming weeks.

Based in St. Paul, Minn., St. Jude Medical is dedicated to making life better for cardiac, neurological and chronic pain patients worldwide.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.